These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4068260)

  • 1. [Arachidonic acid metabolism in platelets].
    Harada Y; Katori M
    Rinsho Byori; 1985 Jul; 33(7):722-5. PubMed ID: 4068260
    [No Abstract]   [Full Text] [Related]  

  • 2. Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic acid metabolism.
    Pilo R; Aharony D; Raz A
    Thromb Haemost; 1981 Aug; 46(2):538-42. PubMed ID: 6795741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A major role of ADP in thromboxane transfer experiments: studies in patients with platelet secretion defects.
    Rao AK; Willis J; Holmsen H
    J Lab Clin Med; 1984 Jul; 104(1):116-26. PubMed ID: 6429260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dominant role of thromboxane formation in secondary aggregation of platelets.
    Meyers KM; Seachord CL; Holmsen H; Smith JB; Prieur DJ
    Nature; 1979 Nov; 282(5736):331-3. PubMed ID: 503210
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of thromboxane A2.
    Ambler J; Birch J; Maguire ED; Wallis RB
    Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
    [No Abstract]   [Full Text] [Related]  

  • 6. [Phospholipid metabolism during activation of human platelets--studies on the basis of phospholipid molecular species].
    Kito M
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):209-15. PubMed ID: 1902581
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
    Heinroth I; Block HU; Mest HJ
    Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
    Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
    Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced platelet thromboxane A2 production as a possible cause of defective platelet aggregation in cirrhosis.
    Laffi G; Cominelli F; La Villa G; Fedi S; Pinzani M; Meacci E; Gentilini P
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():366-9. PubMed ID: 2959079
    [No Abstract]   [Full Text] [Related]  

  • 10. Generation of thromboxane A2 and aorta-contracting activity from platelets stimulated with modified C-reactive protein.
    Simpson RM; Prancan A; Izzi JM; Fiedel BA
    Immunology; 1982 Sep; 47(1):193-202. PubMed ID: 7118160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of platelet aggregation by novel benzoylpyrrole derivatives.
    Kurozumi S; Ohtsu A; Hoshina K; Jimba M; Komoriya K; Naruchi T; Wakabayashi T; Hashimoto Y; Ishimoto S
    Adv Prostaglandin Thromboxane Res; 1980; 6():305-7. PubMed ID: 7386272
    [No Abstract]   [Full Text] [Related]  

  • 12. Suppression by beta-lactam antibiotics of thromboxane A2 generation and arachidonic acid release in rabbit platelets in vitro.
    Mihara S; Fujimoto M; Okabayashi T
    Thromb Res; 1986 Nov; 44(3):265-75. PubMed ID: 3798399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimucytin: a collagen-like aggregating inducer isolated from Trimeresurus mucrosquamatus snake venom.
    Teng CM; Ko FN; Tsai IH; Hung ML; Huang TF
    Thromb Haemost; 1993 Mar; 69(3):286-92. PubMed ID: 8470053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelium and platelet preparations for the prediction of xenobiotic effects on the vascular system.
    Togna G; Togna AR; Caprino L
    Xenobiotica; 1985; 15(8-9):661-4. PubMed ID: 3934852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms of thrombocyte aggregation in experimental hypoparathyroidism].
    Chursina IuIa; Amroian EA; Khudaverdian DN
    Biull Eksp Biol Med; 1986 Dec; 102(12):666-8. PubMed ID: 3801615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of thromboxane A2 in platelet aggregation. Preliminary report].
    Mashimo N; Yamaguchi S; Watanabe Y; Mitani J; Sakurada H; Numano F
    Rinsho Byori; 1979; Suppl 40():122-9. PubMed ID: 551220
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of platelet function of antiarrhythmic drugs, verapamil and disopyramide.
    Han P; Boatwright C; Ardlie NG
    Thromb Haemost; 1982 Apr; 47(2):150-3. PubMed ID: 7101234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of etamsylate on platelet functions and arachidonic acid metabolism.
    Okuma M; Takayama H; Sugiyama T; Sensaki S; Uchino H
    Thromb Haemost; 1982 Dec; 48(3):330-3. PubMed ID: 6819650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.